✦ LIBER ✦

Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants

✍ Scribed by McIntyre, Catherine A.; Chapman, Karen; Reeder, Steve; Dorreen, Mark S.; Bruce, Lesley; Rodgers, Sheila; Hayat, Khizar; Schreenivasan, Thiagarajan; Sheridan, Eamonn; Hancock, Barry W.; Rees, Robert C.

Book ID: 122492275
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 804 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(92)90385-F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant melanoma and renal cell carcin

Malignant melanoma and renal cell carcinoma: Immunological and haematological effects of recombinant human interleukin-2

✍ Khizar Hayat; Sheila Rodgers; Lesley Bruce; Robert C. Rees; Karen Chapman; Steve 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 809 KB

A comparison of cytokine levels detected

A comparison of cytokine levels detected in sera and supernatants derived from cultured PBMC from renal cell carcinoma patients undergoing IL2 therapy

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A phase-II study of low-dose cyclophosph

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

✍ Albrecht Lindemann; Klaus Höffken; Reinhold E. Schmidt; Volker Diehl; Otto Kloke 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 937 KB

A combination of subcutaneous recombinan

A combination of subcutaneous recombinant interleukin-2 and recombinant interferon-α in the treatment of advanced renal cell carcinoma or melanoma

✍ Vuoristo, Merisisko; Jantunen, Ismo; Pyrhönen, Seppo; Muhonen, Timo; Kellokumpu- 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 410 KB

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN

Cytokine levels in whole blood cell cult

Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma

✍ Ursula Elsässer-Beile; Sabine von Kleist; Wilfried Stähle; Carola Schurhammer-Fu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views